Sleep disorders in patients with a neurocognitive disorder
CONCLUSION: Multiple and sustained nonpharmacological approaches are recommended for the treatment of sleep disturbances in patients with neurocognitive disorder. Pharmacological indications remain limited, and further randomized clinical trials integrating a multimodal approach are warranted to evaluate the treatment of sleep disorders in specific neurocognitive disorders.PMID:34916075 | DOI:10.1016/j.encep.2021.08.014
Source: L Encephale - Category: Psychiatry Authors: C Moderie J Carrier T T Dang-Vu Source Type: research
More News: Alzheimer's | Brain | Calcium | Clinical Trials | Clonazepam | Dementia | Donepezil | Environmental Health | Insomnia | Iron | Klonopin | Light Therapy | Melatonin | Neurology | Obstructive Sleep Apnea | Parkinson's Disease | Psychiatry | Restless Legs Syndrome | Sleep Apnea | Sleep Disorders | Sleep Medicine | Sports Medicine | Trazodone